167 related articles for article (PubMed ID: 25234798)
1. Costs and work limitation of patients with ankylosing spondylitis in China.
Tu L; Rai JC; Cao S; Lin Z; Hu Z; Gu J
Clin Exp Rheumatol; 2014; 32(5):661-6. PubMed ID: 25234798
[TBL] [Abstract][Full Text] [Related]
2. Healthcare costs and productivity losses directly attributable to ankylosing spondylitis.
Rafia R; Ara R; Packham J; Haywood KL; Healey E
Clin Exp Rheumatol; 2012; 30(2):246-53. PubMed ID: 22409861
[TBL] [Abstract][Full Text] [Related]
3. Costs and quality of life of patients with ankylosing spondylitis in Canada.
Kobelt G; Andlin-Sobocki P; Maksymowych WP
J Rheumatol; 2006 Feb; 33(2):289-95. PubMed ID: 16465660
[TBL] [Abstract][Full Text] [Related]
4. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong.
Zhu TY; Tam LS; Lee VW; Hwang WW; Li TK; Lee KK; Li EK
Rheumatology (Oxford); 2008 Sep; 47(9):1422-5. PubMed ID: 18635597
[TBL] [Abstract][Full Text] [Related]
5. Relationship of work disability between the disease activity, depression and quality of life in patients with ankylosing spondylitis.
Sağ S; Nas K; Sağ MS; Tekeoğlu İ; Kamanlı A
J Back Musculoskelet Rehabil; 2018; 31(3):499-505. PubMed ID: 29504521
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in Turkey.
Akkoç N; Direskeneli H; Erdem H; Gül A; Kabasakal Y; Kiraz S; Balkan Tezer D; Hacıbedel B; Hamuryudan V
Rheumatol Int; 2015 Sep; 35(9):1473-8. PubMed ID: 25749712
[TBL] [Abstract][Full Text] [Related]
7. Understanding presenteeism in patients with ankylosing spondylitis: contributing factors and association with sick leave.
Gordeev VS; Maksymowych WP; Schachna L; Boonen A
Arthritis Care Res (Hoboken); 2014 Jun; 66(6):916-24. PubMed ID: 24339444
[TBL] [Abstract][Full Text] [Related]
8. The burden of ankylosing spondylitis in Spain.
Kobelt G; Sobocki P; Mulero J; Gratacos J; Pocovi A; Collantes-Estevez E
Value Health; 2008; 11(3):408-15. PubMed ID: 18489666
[TBL] [Abstract][Full Text] [Related]
9. Understanding limitations in at-work productivity in patients with active ankylosing spondylitis: the role of work-related contextual factors.
Boonen A; Boone C; Albert A; Mielants H
J Rheumatol; 2015 Jan; 42(1):93-100. PubMed ID: 25362661
[TBL] [Abstract][Full Text] [Related]
10. Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China.
Tu L; Xie Y; Liao Z; Jiang Y; Lv Q; Cao S; Wei Q; Gu J
Front Public Health; 2020; 8():602334. PubMed ID: 33330342
[No Abstract] [Full Text] [Related]
11. Functional limitation and associated factors in outpatients with ankylosing spondylitis in Southwest China.
Song Y; Wang C; Chen H
Clin Rheumatol; 2017 Apr; 36(4):871-877. PubMed ID: 28168660
[TBL] [Abstract][Full Text] [Related]
12. Assessment of work disability in seronegative spondyloarthritis.
Rohekar S; Pope J
Clin Exp Rheumatol; 2010; 28(1):35-40. PubMed ID: 20346236
[TBL] [Abstract][Full Text] [Related]
13. Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies.
Cardiel MH; Londoño JD; Gutiérrez E; Pacheco-Tena C; Vázquez-Mellado J; Burgos-Vargas R
Clin Exp Rheumatol; 2003; 21(4):451-8. PubMed ID: 12942696
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic impact of ankylosing spondylitis in Tunisia.
Younes M; Jalled A; Aydi Z; Zrour S; Korbaa W; Ben Salah Z; Letaief M; Bejia I; Touzi M; Bergaoui N
Joint Bone Spine; 2010 Jan; 77(1):41-6. PubMed ID: 20022534
[TBL] [Abstract][Full Text] [Related]
15. The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey.
Malhan S; Pay S; Ataman S; Dalkilic E; Dinc A; Erken E; Ertenli I; Ertugrul E; Gogus F; Hamuryudan V; Inanc M; Karaarslan Y; Karadag O; Karakoc Y; Keskin G; Kisacik B; Kiraz S; Oksel F; Oksuz E; Pirildar T; Sari I; Soy M; Senturk T; Taylan A
Clin Exp Rheumatol; 2012; 30(2):202-7. PubMed ID: 22546069
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Analyses of Presenteeism and Its Role as a Predictor of Sick Leave in Patients With Ankylosing Spondylitis.
Tran-Duy A; Nguyen TT; Thijs H; Baraliakos X; Heldmann F; Braun J; Boonen A
Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1578-85. PubMed ID: 26216525
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study on factors associated with poor work outcomes in patients with axial spondyloarthritis in Singapore.
Goh Y; Kwan YH; Leung YY; Fong W; Cheung PP
Int J Rheum Dis; 2019 Nov; 22(11):2001-2008. PubMed ID: 31576680
[TBL] [Abstract][Full Text] [Related]
18. The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008.
Petříková A; Doležal T; Klimeš J; Vocelka M; Sedová L; Kolář J
Rheumatol Int; 2013 Jul; 33(7):1813-9. PubMed ID: 23314983
[TBL] [Abstract][Full Text] [Related]
19. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
[TBL] [Abstract][Full Text] [Related]
20. Resource utilisation and cost of ankylosing spondylitis in Brazil.
Torres TM; Ferraz MB; Ciconelli RM
Clin Exp Rheumatol; 2010; 28(4):490-7. PubMed ID: 20810034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
